CPhi Preview 2013: Jost Chemicals - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

CPhi Preview 2013: Jost Chemicals


Untitled Document

2013 CPhI Exhibitor Preview

Company: Jost Chemical Co.

Description: For almost 30 years, Jost Chemical Co. has manufactured high purity inorganic chemicals for use in API synthesis, as pH buffers, as process intermediates, and in cell culture media and protein synthesis. Jost’s FDA registered site operates under bulk pharmaceutical cGMP. Jost is a global supplier of high purity salts that meet USP/EP/BP/JP monographs, are BSE/TSE free, and Kosher and Halal certified. Our wide selection of 250 + products includes carbonates, nitrates, phosphates and sulfates. Jost also offers DMF and ASMF developments.

Website: www.jostchemical.com

Booth Number: Hall 5.1 Stand D40

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
26%
Attracting a skilled workforce
29%
Obtaining/maintaining adequate financing
14%
Regulatory compliance
31%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Obama Administration Halts Attack on Medicare Drug Plans

Click here